More clinical benefits of molnupiravir ID’d in COVID-19
Jun 07, 2022
New benefits for certain COVID-19 patients, including reduced need for respiratory intervention, have been found for Merck’s COVID-19 pill molnupiravir.
White House urges greater use of Paxlovid as supply increases
By
Alicia Lasek
Apr 28, 2022
Health officials are encouraging physicians to more frequently consider prescribing the oral antiviral now that it is no longer in short supply.
Long-term care facilities to receive expedited meds under National COVID-19 Preparedness Plan
By
Alicia Lasek
Mar 03, 2022
Hundreds of facilities will be able to directly order COVID-19 antiviral drugs and receive direct distributions starting this month, federal officials say.
Feds press pause on LTC monoclonal antibody mainstays, approve two COVID-19 pills
By
Alicia Lasek
Jan 04, 2022
Federal officials have halted further allocation of certain monoclonal antibody drugs — including REGEN-COV. But clinicians may soon have access to two new oral drugs intended for at-risk patients with...
